EligibleTrials

BAROSTIM THERAPY™ in Heart Failure With Reduced Ejection Fraction

Recruiting · NCT02880618 · Observational (researchers observe without assigning treatment)

View the official record on ClinicalTrials.gov →
Heart Failure

Interventions studied

Barostim Neo™ System

What this trial is about

The purpose of this registry (NCT02880618) is to evaluate the effect of BAROSTIM THERAPY with the BAROSTIM NEO System in the commercial setting in subjects recently implanted under the CE-Marked indication for heart failure with reduced ejection fraction (HFrEF).

Who can take part

Age range
No age limits stated
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)

Inclusion criteria

Exclusion criteria

Where it is running

30 locations listed.

Read the full protocol, contacts and eligibility on ClinicalTrials.gov →

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.